Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-09-02
1989-08-08
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514423, A61K 3140
Patent
active
048553158
ABSTRACT:
Zofenopril, and pharmaceutically acceptable salts thereof, can be used for the treatment of rheumatoid arthritis.
REFERENCES:
patent: 4235885 (1980-11-01), Sundeen et al.
patent: 4263293 (1981-04-01), Sundeen et al.
patent: 4297275 (1981-10-01), Sundeen et al.
patent: 4316906 (1982-02-01), Ondetti et al.
patent: 4327111 (1982-04-01), Sundeen et al.
patent: 4382081 (1983-05-01), Sundeen et al.
patent: 4424354 (1984-01-01), Sundeen et al.
Johnsen et al., "Immunosuppressive Action of Captopril Blocked by Prostaglandin Synthetase Inhibitor", Lancet, May 2, 1981, p. 1005.
Kallenberg et al., "Captopril and the Immune System", Lancet, Jul. 11, 1981, p. 92.
Merlet et al., "Captopril in Rheumatoid Arthritis", Revue Du Rheumatisme, XVth International Congress of Rheumatology, 1981, #1389 (Abstract).
Martin et al., "Captopril, A New Long Term Agent for Treating Rheumatoid Arthritis", The Heberden Society Annual Meeting and Oration (1982).
Martin et al., "Captopril: A New Treatment for Rheumatoid Arthritis", Lancet, Jun. 16, 1984, p. 1325.
Drury et al., "Captopril in Rheumatoid Arthritis", Lancet, Jul. 7, 1984, pp. 36 and 37.
Jaffe, "Angiotensin Converting Inhibitors in Rheumatoid Arthritis", Arthritis and Rheumatism, 27(7): 840 (1984).
Traficante et al., "Angiotensin Converting Enzyme Inhibitors and Rheumatoid Arthritis", Arthritis and Rheumatism, 28:480 (1985).
"Criteria for Diagnosis and Classification of Rheumatic Diseases", JAMA, 224(5): pp. 799 to 802 (1973).
Dixon et al., "Biochemical and Clinical Changes Occurring During the Treatment of Rheumatoid Arthritis with Novel Antirheumatoid Drugs", International Journal of Clinical Pharmacology in Research, V(1):25-33 (1985).
Jaffe, "Adverse Effects Profile of Sulfhydryl Compounds in Man", American Journal of Medicine, 80:471 (Mar., 1986).
"Angiotensin Converting Enzyme Inhibitors", Kostis et al. editors, Alan R. Liss, Inc., New York (1987), pp. 109 and 203.
Ward et al., "Interim Observations on the Benefits/Risk of Azathioprine Versus D-Penicillamine in the Treatment of Rheumatoid Arthritis", Ann. Rheum. Dis. 41 (Suppl): 23 (1982).
Williams et al., "Comparison of Low-Dose Oral Pulse Methotrexate and Placebo in the Treatment of Rheumatoid Arthritis", Arthritis and Rheumatism 28:721 (1985).
Pinals et al., "Preliminary Criteria for Clinical Remission in Rheumatoid Arthritis", Arthritis and Rheumatism 24:1308 (1981).
Barrack Donald J.
E. R. Squibb & Sons Inc.
Friedman Stanley J.
Gaul Timothy J.
LandOfFree
Use of zofenopril for the treatment of rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of zofenopril for the treatment of rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of zofenopril for the treatment of rheumatoid arthritis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-905849